The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Preformed Line Products Co
F:P4L
|
US |
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
JP |
|
R
|
Rockwell Automation Inc
F:RWL
|
US |
|
H
|
Henkel AG & Co KGaA
DUS:HEN
|
DE |
|
C
|
CB Industrial Product Holding Bhd
KLSE:CBIP
|
MY |
|
V
|
Vodafone Group PLC
DUS:VODJ
|
UK |
|
Avi Ltd
F:IZ6
|
ZA |
|
D
|
Denso Corp
OTC:DNZOF
|
JP |
|
D
|
Daesung Microbiological Labs Co Ltd
KOSDAQ:036480
|
KR |
|
Koyo International Ltd
SGX:5OC
|
SG |
|
Kernel Holding SA
OTC:KARNF
|
UA |
|
W
|
Worley Ltd
OTC:WYGPF
|
AU |
|
G
|
Getlink SE
SWB:TNU3
|
FR |
|
M
|
Medtronic PLC
XMUN:2M6
|
IE |
|
P
|
Perenti Global Ltd
F:FWG
|
AU |
|
E
|
Endeavour Mining plc
XMUN:6E2
|
UK |
|
G
|
Greggs PLC
XMUN:41G1
|
UK |
|
K
|
KME Group SpA
F:MTJ3
|
IT |
|
U
|
Unum Group
DUS:UUM
|
US |
|
N
|
Netflix Inc
XMUN:NFC
|
US |
|
Avi Ltd
F:IZ60
|
ZA |
|
P
|
Pro Medicus Ltd
F:PMC
|
AU |
|
Koninklijke Ahold Delhaize NV
MIL:1AD
|
NL |
|
UiPath Inc
NYSE:PATH
|
US |
Preformed Line Products Co (P4L)’s 12-month stock price forecast through September 2027 has a consensus target of €213.85, implying 38% downside. The forecast is based on price targets from 3 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
P4L is 213.85 EUR with a low forecast of 211.76 EUR and a high forecast of 220.14 EUR.
Over the last 13 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 3 years is 13%.
Over the last 13 years, the compound annual growth rate for Gross Profit has been 3%. The projected CAGR for the next 3 years is 15%.
Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 3 years is 23%.
Over the last 13 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 3 years is 30%.
AI-generated answers can contain mistakes, outdated facts, or incomplete information. Always verify important details before making decisions.
The AI Assistant is designed for research and education. It does not provide personalized investment, legal, or tax advice.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more